Srivicha Krudsood is a Professor in the Department of Tropical Hygiene. She
obtained her Doctor of Medicine degree from Far Eastern University,
Philippines, and M.Sc. and Ph.D. in Clinical Tropical Medicine from Mahidol
University, Thailand. She holds diplomas in Tropical Medicine and Hygiene from
the Thai Board in Internal Medicine at Mahidol University and from Thai Medical
Council, respectively. Dr. Srivicha is an authority on national policies and
strategies for treatment and elimination of malaria in Thailand.
Srivicha is an established malariologist, specializing in malaria treatment
studies. She has extensive experience in conducting anti-malarial clinical drug
trials. She is currently involved with the pharmaceutical development of the
FDA-approved drug tafenoquine, a 3-day-dose radical cure for vivax malaria. Dr.
Srivicha is a renowned expert in the clinical management of malaria, providing
consultancy services that inform and influence Thai national malaria policy.
|Research Name||Funding Source|
|• Evaluation of Malaria Deyection Function Leveraging New Product in Thailand
|National Center for Global Health and Medicine, Japan|
|2009||Ph.D. (Tropical Medicine) , Faculty of Tropical Medicine||Mahidol University, Thailand|
|1996||Diplomat, Thai Board in Internal Medicine||The Medical Council of Thailand|
|1993||M.Sc. (Clinical Tropical Medicine), Faculty of Tropical Medicine||Mahidol University, Thailand|
|1992||Diploma in Tropical Medicine and Hygiene, Faculty of Tropical Medicine||Mahidol University, Thailand|
|1990||M.D., Faculty of Medicine||Far Eastern University (Nicanor Reyes of Medical Foundation), Philippines|
|1984||B.Sc. (Biology), Faculty of Science||Chulalongkorn University, Thailand|